This compound is a pharmaceutical impurity standard, specifically a derivative of the angiotensin II receptor antagonist losartan. It is characterized as a chlorinated imidazole methanol bearing a trityltetrazole-substituted biphenyl moiety and is used in quality control for pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 124751-00-4
Trityllosartan
pharmaceutical intermediate
3-Methylclobazam
pharmaceutical raw material
1-AMINOADAMATANE, 3-METHYL
pharmaceutical raw material
N,N-Bis({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
pharmaceutical raw material
Descyclopropyl abacavir
pharmaceutical raw material
Dynemicin A
pharmaceutical raw material
Pitofenone hydrochloride
pharmaceutical raw material
Valacyclovir hydrochloride
pharmaceutical raw material
[2-butyl-5-chloro-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
ZKJNVODQIYQUNQ-UHFFFAOYSA-N
CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=NN4C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)CO)Cl